SEC 10-K / 10-Q · Updated Daily

ATNM

— ACTINIUM PHARMACEUTICALS, INC. Financials

Standardized 10-K and 10-Q line items with working capital, liquidity, solvency, profitability, efficiency, and cash-flow ratios — each chartable over any trailing window of filings, with every number confirmable against the original SEC document.

Financials Ownership

Latest Filing Snapshot — 10-Q for period ended 2026-06-30

Metric	Value	What it means
Current Ratio	4.08	Current assets ÷ current liabilities. Above 1 means short-term assets cover short-term obligations.
Debt-to-Equity	0.33	Total liabilities ÷ stockholders' equity — how much of the company is financed by debt vs. equity.
Net Margin	79.72%	Net income ÷ revenue.
Return on Equity	92.08%	Net income ÷ stockholders' equity.

Raw Line Items

Liquidity

Solvency & Leverage

Profitability

Efficiency

Cash Flow

Current Ratio

Not enough filings with this line item yet.

All Filings

Form	Fiscal Period	Period End	Filed
10-Q	—	2026-06-30	2026-08-07
10-Q	—	2026-03-31	2026-05-08
10-K	—	2025-12-31	2026-03-30
10-Q	—	2025-09-30	2025-11-14
10-Q	—	2025-06-30	2025-08-08
10-Q	—	2025-03-31	2025-05-09
10-K	—	2024-12-31	2025-03-31
10-Q	—	2024-09-30	2024-11-14
10-Q	—	2024-06-30	2024-08-05
10-Q	—	2024-03-31	2024-04-26
10-K	—	2023-12-31	2024-03-29
10-Q	—	2023-09-30	2023-11-02
10-Q	—	2023-06-30	2023-08-14
10-Q	—	2023-03-31	2023-05-15
10-K	—	2022-12-31	2023-03-31
10-Q	—	2022-09-30	2022-11-14
10-Q	—	2022-06-30	2022-08-12
10-Q	—	2022-03-31	2022-05-13
10-K	—	2021-12-31	2022-03-25
10-Q	—	2021-09-30	2021-11-12
10-Q	—	2021-06-30	2021-07-30
10-Q	—	2021-03-31	2021-05-14
10-K	—	2020-12-31	2021-03-31
10-Q	—	2020-09-30	2020-10-23
10-Q	—	2020-06-30	2020-08-14
10-Q	—	2020-03-31	2020-06-29
10-K/A	—	2019-12-31	2020-07-13
10-K/A	—	2019-12-31	2020-06-16
10-K	—	2019-12-31	2020-05-08
10-Q	—	2019-09-30	2019-11-12
10-Q	—	2019-06-30	2019-08-09
10-Q	—	2019-03-31	2019-05-10
10-K	—	2018-12-31	2019-03-15
10-Q	—	2018-09-30	2018-11-09
10-Q	—	2018-06-30	2018-08-09
10-Q	—	2018-03-31	2018-05-10
10-K	—	2017-12-31	2018-03-16
10-Q	—	2017-09-30	2017-11-03
10-Q	—	2017-06-30	2017-08-04
10-Q	—	2017-03-31	2017-05-15
10-K	—	2016-12-31	2017-03-16
10-Q	—	2016-09-30	2016-10-28
10-Q	—	2016-06-30	2016-07-29
10-Q	—	2016-03-31	2016-05-10
10-K	—	2015-12-31	2016-03-11
10-Q	—	2015-09-30	2015-10-30
10-Q	—	2015-06-30	2015-08-07
10-Q	—	2015-03-31	2015-05-08
10-K	—	2014-12-31	2015-03-16
10-Q	—	2014-09-30	2014-10-31
10-Q	—	2014-06-30	2014-08-12
10-Q	—	2014-03-31	2014-05-12
10-K/A	—	2013-12-31	2014-04-10
10-K	—	2013-12-31	2014-02-28
10-Q	—	2013-09-30	2013-11-14
10-Q	—	2013-06-30	2013-08-13
10-Q	—	2013-03-31	2013-05-15
10-K	—	2012-12-31	2013-03-29
10-Q	—	2012-09-30	2012-11-14
10-Q/A	—	2012-06-30	2012-08-29
10-Q	—	2012-06-30	2012-08-20
10-Q	—	2012-03-31	2012-04-23
10-K	—	2011-12-31	2012-04-12
10-Q	—	2011-09-30	2011-11-14
10-Q	—	2011-06-30	2011-08-12
10-Q	—	2011-03-31	2011-04-28
10-K	—	2010-12-31	2011-03-03
10-Q	—	2010-09-30	2010-11-04
10-Q	—	2010-06-30	2010-07-28
10-Q	—	2010-03-31	2010-05-07
10-K	—	2009-12-31	2010-03-16
10-Q/A	—	2009-09-30	2009-12-29
10-Q	—	2009-09-30	2009-11-12
10-Q/A	—	2009-06-30	2009-12-29
10-Q	—	2009-06-30	2009-08-11
10-Q	—	2009-03-31	2009-05-13
10-Q/A	—	2009-03-31	2009-12-29
10-K	—	2008-12-31	2009-02-20
10-K/A	—	2008-12-31	2009-12-29
10-Q	—	2008-09-30	2008-11-10
10-Q	—	2008-06-30	2008-08-14
10-Q	—	2008-03-31	2008-05-08

Source: SEC EDGAR 10-K/10-Q XBRL data. For informational purposes only — not investment advice.